openPR Logo
Press release

Dermatology Drugs Market Key Player Analysis - Allergan Plc, Valeant Pharmaceuticals, Dermira Inc., Aclaris Therapeutics, Inc, AnaptysBio, Inc, Sienna Biopharmaceuticals

10-23-2018 09:56 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Dermatology Drugs Market Key Player Analysis - Allergan Plc,

Polaris Market Research presents a most up-to-date research on “Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022”.

Polaris Market Research assumes that with the expected launch of the potential promising therapies, the market is anticipated to expand in both psoriasis and atopic dermatitis segments. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is due to the increased adoption of high-priced biologics. Despite the launch and availability of multiple biologics, only 10% of the patients have access to these treatments and the market continues to remain underpenetrated.

Request a sample report @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/request-for-free-sample

Major Key Player in the Report are:

• Allergan Plc
• Valeant Pharmaceuticals
• Dermira Inc
• Aclaris Therapeutics, Inc
• AnaptysBio, Inc
• Revance Therapeutics
• Foamix Pharmaceuticals
• Novan, Inc
• Sienna Biopharmaceuticals
• Pfizer
• Sanofi
• Galderma
• Leo Pharma
• Roviant Sciences
• Otsuka Pharmaceuticals.

Currently, the Dermatology Drugs market is highly fragmented but offer several commercial opportunities. There remains significant unmet need for safer and cost-effective treatment options. Psoriasis market was nearly USD 6 billion markets in 2016 due to the existing effective TNF alpha treatments. In Acne, retinoids and antibiotics are the mainstay treatments but what makes this indication lucrative is the promising candidates in the pipeline including Foamix’s FMX-101 and Dermira’s DRM-101.

Dermatology Drugs Market, by Region:

North America - U.S., Canada
Europe - Germany, UK, France
Asia-Pacific – India, Japan, China
Latin America - Brazil, Mexico
Middle East & Africa

Polaris Market Research has provided the forecasts of the Global Dermatology Drugs Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are:

• Market Analysis by Dermatology Key Indications
• Market Analysis by Treatment Class/Marketed Drugs
• Market Analysis by Regions.

Get Customization in the Report, Enquire Now @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market-/inquire-before-buying

The Marketed Therapies undertaken in forecast from 2016-2022 are:

• etanercept; Enbrel
• infliximab; Remicade
• adalimumab; Humira
• ustekinumab; Stelara
• secukinumab; Cosentyx
• ixekizumab; Taltz
• golimumab; Simponi
• brodalumab; Siliq
• guselkamab; Tremfya
• Topical Drugs
• Oral Antibiotics

The Major Indications in Dermatology Therapy area:

• Atopic Dermatitis
• Psoriasis
• Acne
• Rosacea.

Out of all dermatological indications, Psoriasis is the largest with several approved biologics and followed by Acne. Psoriasis affects approximately 8 million patients in the U.S. and roughly 20-30% have moderate to severe psoriasis. Out of them, only 10% of the moderate to severe patients are treated with biologics. Acne is the most commonly treated skin disorders and occurs in adolescents and patients between 15-24 years of age. Despite the size of the market, there is no single best treatment for acne and therefore combinations treatments are often used. Currently, Topical therapies dominate the acne treatment. There remains significant unmet need in the Dermatology drugs market as current treatment options do not offer improved safety, efficacy and tolerability profile often with low patient compliance.

Read More Details @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market-/

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatology Drugs Market Key Player Analysis - Allergan Plc, Valeant Pharmaceuticals, Dermira Inc., Aclaris Therapeutics, Inc, AnaptysBio, Inc, Sienna Biopharmaceuticals here

News-ID: 1320938 • Views:

More Releases from Polaris Market Research & Consulting

Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion by 2032 at 5.6% CAGR
Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion …
New York, April 28, 2024 (Polaris Market Research) According to a research report "Asia Pacific Polyurethane Market by Product (Rigid PU Foam, Flexible PU Foam, PU Coatings, PU Adhesives & Sealants, PU Elastomers), Application, Country - Global Forecast to 2032" published by Polaris Market Research, the market size for polyurethane in Asia Pacific is projected to reach approximately USD 59.45 billion by 2032, as compared to the estimated value of
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a 15.3% CAGR
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a …
New York, April 28, 2024 (Polaris Market Research) The Europe Transcritical CO2 Market, in terms of revenue, was estimated to be worth USD 26.26 billion in 2023 and is foreseen to reach USD 94.20 billion by 2032, growing at a CAGR of 15.3% from 2024 to 2032, according to a recent report by Polaris Market Research. Growing demand in the refrigeration industry for natural refrigerants and energy-efficient solutions is propelling
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR of 7.4% in the Year 2032
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR …
Asia Pacific Energy Drinks Market size and share is currently valued at USD 36.44 billion in 2023 and is anticipated to generate an estimated revenue of USD 68.77 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032 This is due to several factors, including growing
Battery Energy Storage System Market Predicted to Grow Expeditiously to Surpass US$ 54,340.12 Million During 2024-2032
Battery Energy Storage System Market Predicted to Grow Expeditiously to Surpass …
New York, April 28, 2024 (Polaris Market Research) Global Battery Energy Storage System Market size and share is currently valued at USD 6,463.09 million in 2023 and is anticipated to generate an estimated revenue of USD 54,340.12 Million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 26.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.